Chile vs Iceland: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Iceland
100.0%
in 2024
Chile rank
1st
Iceland rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Iceland
How they compare
Chile currently reports 100.0% against 100.0% in Iceland, a difference of 0.0%.
The two have swapped places 6 times across 17 shared years of data; in 2005 it was Iceland ahead.
Chile ranks 1st and Iceland ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Chile | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1% | 100.0% | 95.9% | Iceland |
| 2010s | 53.6% | 92.2% | 38.6% | Iceland |
| 2020s | 96.5% | 50.0% | 46.5% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Iceland?
- Chile, at 100.0% against 100.0% in Iceland as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Iceland?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Iceland?
- 17 years are reported by both, from 2005 to 2024.
- How do Chile and Iceland rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Iceland ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.